Oral Plenary Session 2 – Fellows Plenary

Oral Plenary Session 1
Publicado: (2025)

ORAL PLENARY SESSION 2: (Fellows Plenary)
Publicado: (2025)

Oral Concurrent Session 2 Diabetes
Publicado: (2026)

Oral Concurrent Session 2 – Diabetes
Publicado: (2026)

Oral Concurrent Session 2 – Clinical Obstetrics and Quality
Publicado: (2025)

Oral Concurrent Session 7 – Diabetes
Publicado: (2025)

Oral Concurrent Session 5 – Hypertension
Publicado: (2025)

Oral Concurrent Session 5 – Clinical Obstetrics
Publicado: (2026)

Oral Concurrent Session 5 Clinical Obstetrics
Publicado: (2026)

Oral Concurrent Session 3 – Ultrasound and Genetics
Publicado: (2025)

Oral Concurrent Session 3 Fetus and Fetal Intervention
Publicado: (2026)

Oral Concurrent Session 3 – Fetus and Fetal Intervention
Publicado: (2026)

Oral Concurrent Session 4 – Basic and Translational Science
Publicado: (2025)

Oral Concurrent Session 8 – Fetus and Fetal Intervention
Publicado: (2025)

Oral Concurrent Session 1 Medical and Surgical Complications of Pregnancy
Publicado: (2026)

Oral Concurrent Session 1 – Equity, Public Health, and Policy
Publicado: (2025)

Oral Concurrent Session 4 Equity, Public Health, and Public Policy
Publicado: (2026)

Oral Concurrent Session 4 – Equity, Public Health, and Public Policy
Publicado: (2026)

Poster Session 2
Publicado: (2026)

Poster Session 2 Abstracts 398–697
Publicado: (2026)

Poster Session 4
Publicado: (2026)

Poster Session 1
Publicado: (2026)

Poster Session 1
Publicado: (2025)

Poster Session 3 Abstracts 698–997
Publicado: (2026)

Poster Session 1 Abstracts 98–397
Publicado: (2026)

Poster Session 4 Abstracts 998–1297
Publicado: (2026)

2025 SMFM Oral Schedule
Publicado: (2025)

2026 Pregnancy Meeting™ Oral Abstracts
Publicado: (2026)

Low‐Dose Prophylactic Oral Iron Supplementation (Ferrous Fumarate, Ferrous Bisglycinate, and Ferrous Sulphate) in Pregnancy Is Not Associated With Clinically Significant Gastrointestinal Complaints: Results From Two Randomized Studies
por: Nils Thorm Milman, et al.
Publicado: (2024)

Postpartum thromboembolism risk by CHA 2 DS 2 ‐VASc score in patients with atrial fibrillation or flutter during pregnancy
por: Virginia Y. Watkins, et al.
Publicado: (2025)

POSTER SESSION 2: Abstracts 385–665
Publicado: (2025)

Correction to “Maternal laparotomy to fetoscopic myelomeningocele repair in patients with Class 2 obesity is safe and feasible”
Publicado: (2025)

Severe acute respiratory syndrome coronavirus 2 and preterm birth, clinical implications—A register‐based cohort study from Sweden
por: Lisa Berglin, et al.
Publicado: (2025)

Association between adverse pregnancy outcomes and awareness of cardiovascular risk factors: A nuMoM2b‐HHS secondary analysis
por: Elizabeth M. Wendl, et al.
Publicado: (2025)

Optimizing diabetes care in pregnancy: A systematic review of glycemic targets, treatment initiation, and glucose‐lowering pharmacological management for T1DM, T2DM, and GDM
por: Gemma Villanueva, et al.
Publicado: (2026)

An overview of upcoming changes in pregnancy and lactation labeling information
por: Juan F. MOSLEY II
Publicado: (2015)